YOLFTbeta
Tristel

Tristel

TSTL · LSE · Healthcare / Medical Instruments & Supplies

392.50GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close392.50
Open392.50
Day Range379.84 – 400.00
52-Week Range336.71 – 450.00
Volume156.30K
Market Cap204.31M
P/E (TTM)26.56
Forward P/E20.88
EPS0.16
Dividend Yield3.34%
Beta0.35
50-Day Avg412.48
200-Day Avg400.02

About

Tristel plc develops, manufactures, and sells infection prevention products in the United Kingdom, Australia, Germany, Western Europe, and internationally. The company operates through three segments: Hospital Medical Device Decontamination, Hospital Environmental Surface Disinfection, and Other. It offers device decontamination products, including wipes system, ULT, OPH, Stella system, fuse for Stella, rinse assure, clean, EVE, medistel, EVA system, daisygrip, fuse for surfaces, dosing system, airstel, enzystel, DOK, pre-clean wipes, rinse wipes, sporicidal wipes, clean for Stella, protect, and wipes; surface disinfection products, such as FUSE, JET, JET LUX, JET PRO, TANK 10 CLO2, TANK 5 CLO2, and TILT 5 CLO2; as well as operates 3T, a cloud-based platform alternative to paper-based traceability systems. The company provides its medical disinfection products, including airway management, cardiology, ear, nose and throat, endoscopy, gastrointestinal physiology, laboratory, ophthalmology, phlebotomy, reproductive health/IVF, surface, ultrasound, urology, women's health, and other products under the Tristel brand. Tristel plc was founded in 1993 and is headquartered in Snailwell, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Christopher Paul Lee
  • Employees270
  • HeadquartersLynx Business Park, Snailwell, United Kingdom, CB8 7NY, UK
  • Websitehttps://tristel.com

Leadership

  • Mr. Christopher Paul LeeCEO & Director · b. 1962
  • Ms. Anna Katarzyna WasylCFO & Director · b. 1980
  • Emily DaveyGlobal Marketing Director
  • Aimee ScarbrowHuman Resources Director
  • Julija ShabanovaExecutive Director

Financials

Income Statement

Currency: GBP2004-04-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Revenue2.18M2.18M3.01M3.75M5.15M5.96M6.85M8.76M9.29M10.94M10.56M13.47M15.33M17.10M20.27M22.22M26.17M31.68M31.00M31.12M36.01M41.93M46.46M
Growth (%)-0.00%+37.84%+24.49%+37.43%+15.79%+14.86%+28.00%+5.97%+17.79%-3.48%+27.58%+13.84%+11.54%+18.53%+9.60%+17.77%+21.05%-2.15%+0.40%+15.70%+16.45%+10.80%
Cost of Revenue965.00K965.00K1.45M1.71M1.89M1.95M2.40M3.12M3.39M3.51M3.54M4.07M4.67M4.55M4.60M5.04M5.50M6.43M6.25M6.46M6.83M8.36M8.52M
Gross Profit1.22M1.22M1.56M2.04M3.26M4.01M4.45M5.64M5.90M7.43M7.01M9.40M10.66M12.55M15.68M17.18M20.66M25.25M24.74M24.66M29.18M33.58M37.94M
Gross Margin55.79%55.79%51.88%54.38%63.29%67.29%64.92%64.40%63.53%67.90%66.43%69.81%69.53%73.40%77.32%77.32%78.97%79.70%79.82%79.23%81.02%80.08%81.65%
Operating Expense1.01M1.01M1.12M1.35M2.48M2.74M3.16M4.14M5.38M8.01M8.75M7.58M8.12M9.99M11.77M13.20M15.97M18.44M19.98M20.46M23.89M26.60M29.54M
Operating Income205.00K205.00K440.00K684.00K781.00K1.27M1.28M1.50M522.00K-583.00K-1.74M1.82M2.54M2.57M3.90M3.98M4.70M6.80M4.76M4.20M5.28M6.98M8.40M
Operating Margin9.39%9.39%14.62%18.26%15.17%21.27%18.74%17.16%5.62%-5.33%-16.46%13.50%16.57%15.01%19.25%17.91%17.95%21.48%15.36%13.48%14.67%16.65%18.07%
EBITDA261.00K261.00K138.55K857.00K994.00K1.58M1.69M2.24M1.20M1.64M-702.00K2.71M3.40M3.55M5.19M5.48M6.17M9.30M6.70M4.46M7.90M10.01M11.47M
EBITDA Margin11.96%11.96%4.60%22.88%19.31%26.57%24.74%25.59%12.89%14.99%-6.65%20.12%22.15%20.73%25.60%24.66%23.58%29.35%21.62%14.31%21.94%23.86%24.70%
Net Income114.00K114.00K39.00K506.00K551.00K1.05M919.00K1.22M476.00K707.00K-1.26M1.30M2.21M2.10M3.42M3.27M4.03M5.10M3.66M987.00K4.46M6.49M6.64M
Net Income Margin5.22%5.22%1.30%13.51%10.70%17.60%13.42%13.86%5.13%6.46%-11.97%9.64%14.45%12.29%16.85%14.73%15.40%16.10%11.79%3.17%12.39%15.47%14.29%
R&D93.00K93.00K110.00K59.00K30.00K38.00K44.00K80.00K98.00K500.00K1.53M410.00K477.00K251.00K665.00K526.00K739.00K458.00K727.00K614.00K694.00K--
R&D as % of Total Revenue4.26%4.26%3.66%1.58%0.58%0.64%0.64%0.91%1.06%4.57%14.53%3.04%3.11%1.47%3.28%2.37%2.82%1.45%2.35%1.97%1.93%--
Interest Expense42.00K42.00K39.00K25.00K1.00K59.00K7.00K20.00K28.00K13.00K20.00K10.00K9.00K105.00K67.00K40.00K1.00K167.00K195.00K195.00K179.00K218.00K259.00K
Interest Expense % of Total Revenue1.92%1.92%1.30%0.67%0.02%0.99%0.10%0.23%0.30%0.12%0.19%0.07%0.06%0.61%0.33%0.18%0.00%0.53%0.63%0.63%0.50%0.52%0.56%

Balance Sheet

Currency: GBP2003-06-302004-04-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Total Assets872.00K872.00K-2.90M3.40M4.68M5.75M6.57M11.95M13.91M14.74M12.75M15.08M17.01M18.79M20.11M22.54M28.49M40.93M39.93M38.74M41.37M44.11M45.33M
Total Liabilities1.03M1.03M-1.21M1.40M2.05M1.44M1.75M3.45M2.00M2.33M1.87M3.00M2.85M3.82M4.05M4.11M5.13M12.47M9.85M9.75M10.68M11.70M12.34M
Total Equity-154.00K-154.00K-1.68M2.00M2.63M4.32M4.83M8.50M11.96M12.50M11.03M12.24M14.16M14.96M16.05M18.42M23.35M28.46M30.08M28.98M30.68M32.41M32.99M
Cash-4.00K-4.00K-1.21M174.00K38.00K81.00K18.00K986.00K441.00K705.00K627.00K2.66M4.04M5.71M5.09M6.66M4.17M6.21M8.09M8.88M7.11M6.14M8.64M
Total Debt469.00K469.00K-59.00K258.00K265.00K106.00K410.00K1.26M116.00K165.00K118.00K50.00K-----6.00M5.91M5.81M5.18M5.86M5.88M
Net Debt473.00K473.00K--1.15M84.00K227.00K25.00K392.00K270.00K-325.00K-540.00K-509.00K-2.61M-4.04M-5.71M-5.09M-6.66M-4.17M-210.00K-2.19M-3.07M-1.93M-275.00K-2.77M

Cash Flow

Currency: GBP2004-04-302004-06-302005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-30
Operating Cash Flow231.00K231.00K269.00K322.00K1.11M535.00K948.00K1.24M-30.00K1.50M709.00K3.27M2.61M4.55M4.35M4.50M5.49M6.99M6.48M5.55M8.49M10.89M10.32M
Investing Cash Flow-272.00K-272.00K-242.00K-1.37M-1.00M-932.00K-893.00K-3.43M-2.38M-992.00K-430.00K-1.08M-1.03M-877.00K-2.54M-1.45M-6.17M-2.97M-1.77M-1.20M-4.84M-5.08M-254.00K
Financing Cash Flow23.00K23.00K1.17M-185.00K-360.00K600.00K-469.00K3.50M1.89M-252.00K-288.00K-213.00K-165.00K-2.12M-2.49M-1.46M-1.83M-2.02M-2.83M-3.62M-5.44M-6.57M-7.30M
Capital Expenditure275.00K275.00K254.00K341.00K1.01M981.00K886.00K3.81M2.41M1.04M476.00K1.16M1.06M905.00K1.00M1.51M1.35M2.38M1.77M1.20M2.42M1.14M857.00K
Free Cash Flow-44.00K-44.00K15.00K-19.00K106.00K-446.00K62.00K-2.57M-2.44M462.00K233.00K2.12M1.55M3.65M3.35M2.98M4.14M4.61M4.71M4.35M6.07M10.06M9.46M
Dividends Paid---185.00K256.00K339.00K422.00K649.00K638.00K156.00K172.00K272.00K752.00K2.62M2.79M1.82M2.21M2.62M3.02M3.09M4.51M6.22M6.66M
FCF to OCF-19.05%-19.05%5.58%-5.90%9.52%-83.36%6.54%-208.42%8143.33%30.82%32.86%64.66%59.30%80.11%76.93%66.34%75.45%65.95%72.72%78.34%71.46%92.40%91.69%
Dividend Paid to FCF----973.68%241.51%-76.01%680.65%-25.21%-26.12%33.77%73.82%12.86%48.55%71.91%83.24%60.97%53.39%56.87%64.04%71.06%74.35%61.87%70.39%

Earnings

Report DateFeb 26, 2016Oct 17, 2016Feb 22, 2017Oct 19, 2017Feb 20, 2018Oct 17, 2018Feb 25, 2019Oct 15, 2019Feb 24, 2020Oct 19, 2020Feb 22, 2021Oct 18, 2021Feb 21, 2022Oct 25, 2022Feb 20, 2023Feb 24, 2025Oct 20, 2025
EPS Estimate0.000.000.000.000.000.000.000.000.000.000.00----0.000.09
EPS Actual0.000.040.030.050.030.040.040.050.050.060.050.060.03-0.010.030.060.08
Surprise-----------------14.35%
Timing------------Pre-marketAfter-hoursPre-market-Pre-market

Key Statistics & Ratios

Market Cap204.31M
Enterprise Value187.23M
Trailing P/E26.56
Forward P/E20.88
PEG Ratio0.00
Price / Sales4.12
Price / Book5.80
EPS0.16
Book Value0.703
Revenue (TTM)49.54M
Gross Profit (TTM)40.45M
EBITDA11.45M
Profit Margin15.88%
Operating Margin19.71%
Return on Equity24.19%
Return on Assets14.46%
Shares Outstanding48.07M
Shares Float46.08M
Beta0.35
Dividend Yield3.34%
Dividend Rate0.14
Payout Ratio1.78%

Dividends

20261×
0.06Mar 19, 2026
20252×
0.09Nov 27, 20250.06Mar 20, 2025
20242×
0.08Nov 28, 20240.05Mar 21, 2024
20232×
0.08Nov 23, 20230.03Mar 16, 2023
20223×
0.04Nov 17, 20220.03Jul 28, 20220.03Apr 7, 2022
20212×
0.04Nov 18, 20210.03Apr 8, 2021
20202×
0.04Nov 19, 20200.02Mar 26, 2020
20192×
0.04Nov 21, 20190.02Mar 28, 2019
20182×
0.03Nov 15, 20180.02Mar 22, 2018
20172×
0.03Nov 16, 20170.01Mar 23, 2017
20163×
0.02Nov 17, 20160.03Jul 28, 20160.01Mar 17, 2016
20151×
0.02Nov 19, 2015